Product
D-Cycloserine
Aliases
Seromycin
Name
SEROMYCIN
INN Name
CycloSERINE
FDA Approved
Yes
4 clinical trials
1 organization
8 indications
1 document
Indication
Suicidal IdeationIndication
SuicideIndication
AttemptedIndication
Major Depressive DisorderIndication
AnxietyIndication
FibromyalgiaIndication
PTSDClinical trial
A Randomized Placebo-controlled Trial of Adjunctive D-Cycloserine and Accelerated Intermittent Theta Burst Stimulation for Emerging Adults With Suicidal IdeationStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Randomized Controlled Trial of Adjunctive D-Cycloserine to Intermittent Theta-burst Stimulation Transcranial Magnetic Stimulation in FibromyalgiaStatus: Active (not recruiting), Estimated PCD: 2026-12-01
Clinical trial
Brain Imaging-based Strategies for Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) PainStatus: Terminated, Estimated PCD: 2016-05-01
Clinical trial
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSDStatus: Withdrawn, Estimated PCD: 2023-12-01
Document
DailyMed Label: SEROMYCINOrganization
Parsolex Gmp Center, Inc.